Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Tandem Diabetes Care, Inc. TNDM
$32.99
+$0.74 (2.26%)
На 18:00, 12 мая 2023
+260.72%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
2197260605.00000000
-
week52high
75.54
-
week52low
31.90
-
Revenue
801217000
-
P/E TTM
-24
-
Beta
0.97577800
-
EPS
-1.57000000
-
Last Dividend
0.00000000
-
Next Earnings Date
01 авг 2023 г. в 10:59
Описание компании
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Wells Fargo | Underweight | Overweight | 09 авг 2022 г. |
| Wells Fargo | Overweight | Overweight | 04 авг 2022 г. |
| Raymond James | Outperform | Outperform | 04 авг 2022 г. |
| Piper Sandler | Overweight | Overweight | 04 авг 2022 г. |
| Citigroup | Buy | Buy | 17 мая 2022 г. |
| OTR Global | Mixed | Positive | 07 сент 2022 г. |
| Barclays | Overweight | 18 окт 2022 г. | |
| Jefferies | Buy | 12 окт 2022 г. | |
| Piper Sandler | Overweight | Overweight | 03 ноя 2022 г. |
| Raymond James | Outperform | Outperform | 04 ноя 2022 г. |
| Wells Fargo | Equal-Weight | Underweight | 15 ноя 2022 г. |
| Wolfe Research | Peer Perform | 26 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Sodhi Rajwant | A | 1070 | 1069 | 04 янв 2023 г. |
| Sodhi Rajwant | A | 2873 | 1069 | 04 янв 2023 г. |
| BERGER DAVID B | A | 10000 | 10000 | 16 дек 2022 г. |
| BERGER DAVID B | D | 3029 | 10000 | 16 дек 2022 г. |
| BERGER DAVID B | A | 13029 | 10000 | 16 дек 2022 г. |
| BERGER DAVID B | A | 20000 | 15000 | 15 дек 2022 г. |
| BERGER DAVID B | D | 3029 | 15000 | 15 дек 2022 г. |
| BERGER DAVID B | A | 18029 | 15000 | 15 дек 2022 г. |
| Carpenter Rick | A | 4871 | 1624 | 15 дек 2022 г. |
| Carpenter Rick | D | 1395 | 562 | 15 дек 2022 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1608270 | -14087 | 31 авг 2020 г. |
| Vanguard Small-Cap Index Fund | 1419460 | -10600 | 31 июл 2020 г. |
| Fidelity Select Medical Technology and Devices Portfolio | 1340000 | -260000 | 31 июл 2020 г. |
| Hartford MidCap Fund | 1328000 | -380727 | 31 июл 2020 г. |
| Alger Small Cap Focus Fund | 928579 | 55056 | 31 июл 2020 г. |
| Vanguard Small-Cap Growth Index Fund | 861902 | -5544 | 31 июл 2020 г. |
| Vanguard Extended Market Index Fund | 811382 | -6010 | 31 июл 2020 г. |
| Fidelity Blue Chip Growth Fund | 710774 | -1978 | 31 июл 2020 г. |
| Fidelity Select Health Care Portfolio | 640000 | -50000 | 31 июл 2020 г. |
| Federated Hermes Kaufmann Fund | 900000 | -50000 | 30 июн 2020 г. |
Новостная лента
Tandem Diabetes (TNDM) Q1 Earnings Miss, Gross Margin Dips
Zacks Investment Research
04 мая 2023 г. в 14:26
According to Tandem Diabetes (TNDM), Q1 revenues are in line with the high end of its expectations.
Tandem Diabetes Care, Inc. (TNDM) Q1 2023 Earnings Call Transcript
Seeking Alpha
03 мая 2023 г. в 23:42
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ET Company Participants Susan Morrison - Executive Vice President and Chief Administrative Officer John Sheridan - President and Chief Executive Officer Brian Hansen - Executive Vice President and Chief Commercial Officer Leigh Vosseller - Executive Vice President and Chief Financial Officer Conference Call Participants Matthew Miksic - Barclays Steven Lichtman - Oppenheimer Christopher Pasquale - Nephron Research Brooks O'Neil - Lake Street Capital Markets Nathan Treybeck - Wells Fargo Securities Danielle Antalffy - UBS Matthew Taylor - Jefferies Matthew O'Brien - Piper Sandler Jayson Bedford - Raymond James Joanne Wuensch - Citi Research Matthew Blackman - Stifel Joshua Jennings - TD Cowen Stephanie Piazzola - Bank of America Securities Alexander Nowak - Craig-Hallum Michael Polark - Wolfe Research Operator Good day and thank you for standing by. Welcome to Tandem Diabetes Care First Quarter 2023 Earnings Conference Call.
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research
03 мая 2023 г. в 19:02
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.23 per share a year ago.
2 Beaten-Down Growth Stocks to Buy in April
The Motley Fool
20 апр 2023 г. в 09:45
Axsome is expecting important developments that should improve its already-bright prospects. Tandem's innovative insulin pump should allow it to capture a larger share of the diabetes market.
Tandem Diabetes Care to Announce First Quarter 2023 Financial Results on May 3, 2023
Business Wire
11 апр 2023 г. в 16:05
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2023 results after the financial markets close on Wednesday, May 3, 2023. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2023 financial and operating results.